CLINICAL_TRIALS
trial_result
· 2008-12-23
Clinical Trial Update: Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer [Phase 2]
Summary
This update notes the completion of a Phase 2 trial evaluating SR 31747A versus placebo in androgen-independent non-metastatic prostate cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Prostatic Neoplasm | Phase 2 | Status: COMPLETED